Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Joint project of the RSC and ESC on webinars with Russian subtitles

31.08.20155403
RSC Board of Educational programmes together with European Society of Cardiology releases ESC webinars with Russian subtitles.

Renal function decline common in patients with AF prescribed anticoagulants

31.08.20151595
Deterioration of renal function, and an increase in related adverse events, may not be unusual in patients with nonvalvular atrial fibrillation prescribed nonvitamin K antagonist oral anticoagulants, according to recent study results in Heart and Vessels.

Five vital anticoagulation reads from the summer

28.08.20152036
Cardiology Today has compiled coverage of major anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in the use and effects of various therapies to manage CVD.

HARMONY: Ranolazine, dronedarone combination benefits patients with paroxysmal AF

27.08.20152021
Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose dronedarone was well-tolerated and reduced atrial fibrillation burden, according to a report in Circulation: Arrhythmia & Electrophysiology.

Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.

25.08.20152612
Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.

Atrial fibrillation risk increases with higher free thyroxine levels

25.08.20151793
Higher free thyroxine levels within the normal range increased the risk for atrial fibrillation, especially among younger adults, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Edoxaban prevents VTE better than enoxaparin after total hip arthroplasty

24.08.20151875
Oral edoxaban showed superior to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.